Aquestive Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Aquestive Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aquestive Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Aquestive Therapeutics by Connor, Clark & Lunn Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $528k | 262k | 2.02 |
2023-09-30 | $379k | 248k | 1.53 |
2023-06-30 | $358k | 217k | 1.65 |
2022-03-31 | $82k | 31k | 2.61 |
2021-12-31 | $110k | 28k | 3.88 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management